Open AccessHematologic adverse drug reactions leading to hospitalization among cancer patients: A retrospective case-control study
Author(s) -
Be Ling Chiou,
Chao-Ching Ho,
Chen Chang Yang
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000298
Subject(s) - medicine , chemotherapy , neutropenia , comorbidity , cancer , pancytopenia , adverse effect , retrospective cohort study , hematologic malignancy , pediatrics , bone marrow
Cancer is one of the leading causes of death worldwide. Despite the rapid evolution of cancer treatment, chemotherapy remains the mainstay in the management of cancer. Chemotherapy can result in various adverse drug reactions (ADRs), which may lead to hospitalization and even life-threatening side-effects. Hematologic ADRs are among the most severe forms of ADR following chemotherapy, as they generally lead to hospitalization. It is important to realize the predictors and outcome of hematologic ADRs in cancer patients.